Procept Biorobotics Corp reports results for the quarter ended June 30 - Earnings Summary

• Procept Biorobotics Corp PRCT.OQ reported a quarterly adjusted loss of 35 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -50 cents. The mean expectation of thirteen analysts for the quarter was for a loss of 41 cents per share. Wall Street expected results to range from -49 cents to -31 cents per share.

• Revenue rose 48.4% to $79.18 million from a year ago; analysts expected $76.40 million.

• Procept Biorobotics Corp's reported EPS for the quarter was a loss of 35 cents​.

• The company reported a quarterly loss of $19.58 million.

• Procept Biorobotics Corp shares had fallen by 16.5% this quarter and lost 40.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 0.5% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

• Wall Street's median 12-month price target for Procept Biorobotics Corp is $77.50, about 37.9% above its last closing price of $48.12

This summary was machine generated from LSEG data August 6 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)